We're a UK-based company that's developed a new generation of DNA/RNA sequencing technology. Founded in 2005 as a spin-out from the University of Oxford, we've grown to over 1,000 people spread across offices in the UK, US, Singapore, and China. Our goal is simple but ambitious: to enable the analysis of anything, by anyone, anywhere.
What makes our technology different is that it offers real-time analysis and can handle everything from pocket-sized devices for field work to high-throughput systems for population-scale projects. Our sequencers can read native DNA and RNA directly, producing short to ultra-long reads that give researchers richer insights. We're not just building tools for genomics anymore - we're exploring applications in proteomics and beyond. Whether it's tracking disease outbreaks, studying cancer, or understanding environmental ecosystems, we've designed our platform to be accessible enough that scientists can use it wherever the questions take them.